Clinical Trials

40 enrolled

Phase 3 Not yet recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07477808 2026-03-17

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

116 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

25 enrolled

Small Cell Lung Carcinoma

NCT07354061 2026-01-21

TD-ENSEMBLE

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07288034 2025-12-17

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

535 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07274384 2025-12-10

HYPERBOLIC

74 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

NCT07271602 2025-12-09

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

104 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Lung Neoplasms

NCT07190027 2025-09-24

Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

246 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07139041 2025-08-24

Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLC

69 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07135882 2025-08-22

PRIME-Lung

420 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07134413 2025-08-21

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

77 enrolled

NSCLC

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT07076836 2025-07-22

Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Phase NA Not yet recruiting

82 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

28 enrolled

Small Cell Lung Carcinoma

NCT06829641 2025-06-27

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

Not yet recruiting

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07035392 2025-06-25

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

32 enrolled

Adebrelimab (SHR-1316)

NCT07035860 2025-06-25

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

Not yet recruiting

34 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06978153 2025-05-18

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

66 enrolled

Limited Stage Small Cell Lung Cancer

NCT06946836 2025-04-27

Neoadjuvant

80 enrolled

Phase 4 Not yet recruiting

Resectable Non-small Cell Lung Cancer

NCT06893354 2025-03-25

Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics

20 enrolled

Phase NA Not yet recruiting

NSCLC

NCT06709274 2024-11-29

MOTION-NSCLC

342 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06614231 2024-09-26

Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer

48 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06613308 2024-09-25

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Not yet recruiting

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06585644 2024-09-05

A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC

44 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06416930 2024-05-16

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Other solid neoplasmThoracic

59 enrolled

Mesothelioma, Malignant

NCT06336954 2024-03-29

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06306560 2024-03-12

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

40 enrolled

Small Cell Lung Carcinoma

NCT05978401 2023-08-07

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

152 enrolled

Advanced Non-Small Cell Lung Cancer

NCT05962021 2023-08-01

Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

126 enrolled

Phase NA Not yet recruiting

Non Squamous Non Small Cell Lung Cancer

NCT05834413 2023-04-28

Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

367 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05186506 2022-01-11

A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer

152 enrolled